Anifrolumab, AstraZeneca Plc’s experimental treatment for lupus, has missed its primary endpoint in a study. The drug failed to meet the goal of a late-stage trial that had 373 patients. Patients in the study did not see a statistically significant reduction in disease activity compared with those who received a placebo in the yearlong study, … Continue reading “AstraZeneca’s Experimental Lupus Treatment Fails to Hit Primary Endpoint”
Author: Sophia Vida
This is How Kylie Jenner Helped Ulta Hit a New 52-Week High
Shares uf Ulta soared to a new 52-week hgih after announcing that Kylie Cosmetics would…
Coca-Cola Will Acquire Coffee Chain Costa for $5.1 Billion
In an effort to move to healthier options, much like how PepsiCo did by saying…
Ford Decides to Kill Plan to Sell a Chinese Made Vehicle in the U.S.
Ford's head of North American operations announced on Friday that the automaker has killed a…
Insys Therapeutics Skyrockets on FDA Fast Track Designation
Shares of Insys Therapeutics were on the rise in Thursday's trading session after the company…
Apple Just Announced When The New iPhones Will Be Unveiled
iPhone enthusiasts better mark their calendars because Apple is expected to unveil its new iPhones…
Signet Sees its Best Trading Day in Over 20 Years
Signet, which operates over 3,500 stores primarily under the name brands of Kay Jewelers, Zales,…
This Firm Just Gave Amazon the Highest Price Target on Wall Street
Morgan Stanley has not only reiterated an "overweight" rating on e-commerce giant Amazon, but has…
Under Armour Shares Just Got Slammed After Dicks’ Sporting Goods Said This
Shares of Under Armour saw a dive on Wednesday after Dick's Sporting Good's called the…
Facebook Just Made a Huge Commitment to This Initiative
Facebook announced plans this week that shows the social media giant is planning to do…
Florida Shooting Prompts EA to Cancel “Madden” Qualifier Events
Video game maker Electronic Arts (EA) has cancelled its 'Madden' qualifier events after a mass…
This Analyst Says Buy McDonald’s For This Reason
One analyst is feeling very bullish on fast food king McDonald's. Jefferies analyst Andy Barish…
Survey Says This Many Companies are Involved with Blockchain on Some Level
According to a new survey, 84% of companies are now dabbling in blockchain. A PwC…
POW Hero John McCain Has Died and Trump Had This to Say About It
Senator John Sidney McCain III passed away this week at the age of 81. He…
